New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb ...

A study on FUO in Guinea found diverse bacterial and viral infections, frequent misdiagnoses, and high antibiotic resistance, ...

Broad-Spectrum Antiviral NV-387 Phase II Clinical Trial Responding to MPox Pandemic in Africa, Readying to Tackle Bird Flu ...

In a global first, Uganda's Ministry of Health, the World Health Organization (WHO) and other partners on Feb.03 launched a first-ever clinical efficacy trial for a vaccine from Ebola from the Sudan ...

The WHO South-East Asia Region (SEAR), with its high population density, is recognised by epidemiologists as a critical ...

KAMPALA, Uganda — Ebola cases in Uganda have risen to nine, while 265 other people were being monitored under quarantine, ...

Observational studies are critical tools in clinical research and public health response, but challenges arise in ensuring ...

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...

In an unprecedented move, Uganda's rapid launch of an Ebola vaccine trial is not only a significant scientific milestone, but also a bold statement that the world can no longer afford to wait for ...

There are no approved vaccines or treatments for Sudan virus disease, which has a 40–70% fatality rate. To curb the ongoing outbreak, Uganda has deployed—under a clinical trial setting—a vaccine ...

Determining the species that are more likely to host such viruses can help identify potential areas in danger and prevent ...

U.S. health officials on Wednesday urged Americans traveling to Uganda to take precautions because of an Ebola outbreak — and said they are helping Ugandan health officials respond to the threat ...